Toll Brothers and Brookfield Residential announced LakePointe, a new master-planned community in Covington, Washington, just 35 minutes from downtown Seattle. The community will feature modern single-family homes and townhomes with lakeside views, parks, trails, and future retail spaces. Sales are expected to start mid-2027, with easy access to major highways enhancing commuter convenience. This project aims to offer luxury living combined with natural surroundings and urban accessibility.
The new master-planned community announced by Toll Brothers and Brookfield Residential provides context for real estate market activity. For readers following the US Real Estate sector, here is Pluang's market snapshot as of Oct 15, 2026 00:51 WIB: out of 47 priced stocks, 9 rose and 37 fell. Digital Realty Trust (DLR) traded at USD 173.27 with a 1-day change of -2.73%, while Iron Mountain Inc (IRM) was at USD 111.49, down 2.71%.
Jefferies has maintained a Buy rating on Big Yellow Group despite recent stock declines, citing the company's strong fundamentals including freehold properties and solid cash flows. Activist investor Ancora, holding over 4% of shares, is pushing Big ...
Fastenal reported strong Q3 2026 earnings, beating analyst expectations with EPS of $0.35 and revenue of $2.46 billion. The company saw a 20% rise in net income to $401.6 million and a 15.5% increase in revenue driven by robust manufacturing demand, ...
Remittix announced the public launch of its RTX token on November 24, 2026, marking the end of its presale phase which raised over $32 million from 40,000 participants. The project is testing its PayFi platform, which enables crypto-to-fiat and fiat-...
The global microbiology testing market is projected to grow rapidly at a compound annual growth rate (CAGR) of approximately 9% from 2026 to 2034, reaching a market size of $13.7 billion by 2034. This growth is driven by the rising prevalence of infe...
H.C. Wainwright raised its price target for Alector from $5.00 to $8.00, maintaining a Buy rating due to progress in its neurodegenerative disease pipeline. Alector develops treatments for Alzheimer's and Parkinson's using its Brain Carrier platform ...
